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Interaction of oxidized low-density lipoprotein (LDL) with arterial smooth muscle cells (SMC) is believed to play a key role in the
development of atherosclerosis. Depending on the extent of oxidation, apolipoproteins and/or lipids in the particle may be modified and thus
lead to different cellular responses (e.g. proliferation or cell death). Here we report on the signaling effects of LDL, in which only the lipids
were oxidized. This so-called minimally modified LDL (mmLDL) mainly activated components involved in stress response and apoptotic
cell death including p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase/stress-activated protein kinase (JNK) as well
as neutral and acid sphingomyelinase. In contrast, proliferative signaling elements such as extracellular regulated kinase, AKT-kinase and
phospho-BAD seem to play a minor role as they were only slightly stimulated by mmLDL.
Ceramide, the hydrolysis product of sphingomyelin, seems to be a key mediator as it mimics mmLDL by inducing activation of the same
signaling components. Moreover, mmLDL- and ceramide-associated effects on apoptotic protein kinases were abolished by NB6, a specific
inhibitor of acid sphingomyelinase. Thus, acid sphingomyelinase is very likely to be primarily responsible for triggering intracellular signal
transduction in SMC after exposure to mmLDL via formation of ceramide by an autocatalytic mechanism.
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The presence of oxidized low-density lipoprotein (LDL)
in plasma and the arterial wall plays a main role in the
development of atherosclerosis as a consequence of protein
and lipid oxidation in the particle [1]. Much is known0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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with macrophages, endothelial cells and smooth muscle
cells (SMC), and their contribution to the formation of
atherosclerotic plaques [2]. In this context, smooth muscle
cells are especially important as they change their cell type
after interaction with oxLDL [3], proliferate and migrate
from the arterial media into the intima where they continue
to proliferate and produce collagenous fibers and extracel-
lular matrix [4]. In addition, in the late phase of athero-
sclerosis they may undergo cell death by necrosis or
apoptosis [5], which is detrimental for the stability of the
plaques. The mechanisms underlying oxLDL-triggered
apoptosis or proliferation of smooth muscle cells are still
not fully understood. So far, only studies have been carried
out concerning the effects of highly oxidized LDL on
signaling pathways using lipoproteins that were both
oxidized at their protein and lipid moieties [6]. Thus, a
specific role of the lipid and protein components in this
scenario could not be identified.
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a physiologically very useful model, as it is only (or perhaps
mainly) oxidized in the lipid domain [7]. It contains, in
contrast to oxLDL, a largely intact apolipoprotein and is still
recognized by the LDL receptor [8]. We addressed ourselves
to the question as to whether mmLDL as compared to native
LDL is able to trigger signaling pathways leading to
apoptosis or proliferation of smooth muscle cells. The
emphasis of our studies was the role of the protein kinases
involved and the potential function of ceramide, a lipid
mediator responsible for the induction of various cellular
events like apoptosis, migration, and proliferation [9]. In this
context, we tried to find out whether it is an upstream
element of mmLDL-induced MAP kinase activation.
Ceramideq, is generated from sphingomyelin by the action
of sphingomyelinases (SMase) [10]. Several isoforms of
these enzymes have been identified but mainly two are
important for signal transduction, namely acid and neutral
sphingomyelinase (nSMase) [11]. Our work was aimed at
identifying the sphingomyelinase involved in signaling
pathways in smooth muscle cells triggered by mmLDL.
In this study, we investigated the effects of mmLDL on c-
Jun N-terminal kinase (JNK) and p38 MAPK, which are
involved in apoptotic and stress response. Furthermore,
activation of the protein kinases ERK and AKT which
participate in proliferative and survival pathways was stud-
ied. Experiments with a new compound N,N,N-(3-carbazo-
lylpropyl)-( p-methoxyphenylethyl)methylamine (NB6) as a
specific inhibitor of acid sphingomyelinase (aSMase) on the
transcriptional level [12], were performed to examine the
role of aSMase as an upstream element in mmLDL-induced
activation of kinases cascades.2. Materials and methods
2.1. Materials
Chemicals were purchased from Merck (Darmstadt,
Germany). Plasticware for cell culture was from Sarstedt
(Nu¨rmbrecht, Germany). Media and supplements for cell
culture were purchased from Paa Laboratories (Linz, Aus-
tria). C6-Ceramide was from Calbiochem (La Jolla, CA).
NB6 was kindly provided by Hans-Peter Deigner (Clinic
for Anaesthesiology and Intensive Care Therapy, FSU
Jena, Germany). D609 was from Tocris Cookson (Avon-
mouth, UK). Chemicals for gel-electrophoreses were pur-
chased from Bio-Rad Laboratories (Hercules, CA).
Nitrocellulose membranes were from Schleicher & Schuell
(Dassel, Germany). Primary polyclonal antibodies against
phosphorylated forms of JNK, p38 MAPK, ERK1/2, AKT
and BAD and against the nonphosphorylated proteins were
purchased from New England Biolabs (Beverly, MA).
Primary antibody against ASM was from Santa Cruz
Biotechnology Inc (Santa Cruz, CA). Alkaline phospha-
tase-conjugated secondary antibodies and 5-bromo-4-chloro-3-indolylphosphate/nitro blue tetrazolium (BCIP/
NBT) liquid substrate system for alkaline phosphatase were
from Sigma (Vienna, Austria).
2.2. Cell culture
Human transformed smooth muscle cells (ACBRI #443
Human Coronary Artery smooth muscle cells from Applied
Cell Biology Research Institute, Kirkland, WA, USA) were
routinely grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% FCS, 2 mM L-glutamine,
100 U/ml penicillin/streptomycin and 25 mM Hepes at
37jC q in humidified CO2 (8%) atmosphere. For SMase
experiments and Western blot analysis of cell lysates, cells
were growth-arrested by incubation with DMEM+ 0.1%
FCS for 24 h prior to treatment with native LDL, mmLDL,
ceramide, or NB6 in DMEM+0.1% FCS.
2.3. Isolation and modification of LDL
Human LDL (d = 1.019–1.063) was isolated from pooled
fresh plasma using a Beckman NVT-rotor [13]. LDL was
minimally modified (mmLDL) as described by Watson [14]
and sterile filtered to avoid endotoxin contamination.
According to the described procedure, mildly oxidized
LDL was obtained. It is characterized by a moderate content
of lipid peroxidation products (30–60 nmol of peroxide
equivalents/mg of apolipoprotein B [15], a slightly en-
hanced electrophoretic mobility (REM) (0.34) as compared
to native LDL (0.30) in 0.8% agarose gels z and an intact
protein moiety.
The protein content of isolated and modified LDL was
determined by the method of Lowry et al. [16].
The whole isolation and modification procedure was
carried out under sterile conditions.
Solutions were prepared using endotoxin-free water
followed by sterile filtering.
2.4. Determination of sphingomyelinase activity
Human arterial smooth muscle cells (HASM) were
grown in six-well plates to 80% q confluency, growth-
arrested with DMEM+0.1% FCS for 24 h and incubated
afterwards with native LDL, mmLDL (60 Ag apo B/ml) or
C6-ceramide (10 AM) for 30 min. For studying the effects of
NB6 and D609, respectively, cells were pretreated with 10
AM of the respective substance for 30 min. NB6 was
removed afterwards and cells were then exposed to mmLDL
or ceramide as indicated above.
After treatment of smooth muscle cells with the respec-
tive compounds, cells were washed with cold PBS, scraped,
harvested and lysed by incubation with neutral lysis buffer
for determination of nSMase activity or acid lysis buffer for
determination of aSMase activity as described previously
[17]. Cell lysates were subjected to protein quantification
after the method by Bradford [18] and aliquots containing
Fig. 1. Effects of native LDL, mmLDL and ceramide on phosphorylation
and activation of MAPKs. HASM were incubated with native LDL,
mmLDL (60 Ag apo B/ml, each) or ceramide (10 AM) for 5, 10 and 30 min.
Activation (phosphorylation) of JNK, p38 MAPK and ERK was analyzed
by Western blotting with anti-phospho-JNK/SAPK, anti-phospho-p38
MAPK, anti-phospho-ERK 1/2 antibodies. Western blot analysis of total
JNK, p38 MAPK and ERK was performed with anti-JNK, anti-p38MAPK
and anti-ERK antibodies, respectively, for ensuring equal loading of each
lane. Data are representative of three independent experiments.
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using fluorescent sphingomyelin as described [17].
2.5. Western blot analysis of ASM and phosphorylation of
JNK, p38 MAPK, ERK1/2, AKT and BAD
HASM were grown in petri dishes (F= 10 cm) to 80%
confluency in DMEM+10% FCS, growth-arrested for 24
h in DMEM+0.1% FCS and incubated afterwards with
native LDL, mmLDL (60 Ag apo B/ml) or C6-ceramide (10
AM) for 5–30 min in DMEM+0.1% FCS. Additionally,
cells were pretreated with NB6 (10 AM) for 30 min before
incubation with mmLDL and ceramide for 30 min. After
treatment with the respective compounds, cells were washed
with ice-cold PBS, scraped, harvested and lysed with
homogenization buffer (20 mM Hepes-Na, 2 mM EDTA-
Na2, 10 mM EGTA, 300 mM sucrose, 10 mM DTT, 1 mM
PMSF, 300 AM NaF, 10 Ag/ml leupeptin, 10 Ag/ml benza-
midin, 10 Ag/ml soya bean trypsin inhibitor, 1% Triton X-
100, pH 7.6) followed by freezing at  80 jC, thawing and
vortexing. The protein content of cell lysates was deter-
mined by the method of Bradford [18] and aliquots con-
taining 20 Ag protein were subjected to SDS-PAGE on 12%
acrylamide gels using the mini-PROTEAN III electropho-
resis cell according to Laemmli [19]. Proteins were trans-
ferred electrophoretically to nitrocellulose membranes.
Unspecific binding was blocked by incubation of the
membranes with 1% bovine serum albumin (BSA) in
incubation buffer (50 mM Tris, 150 mM NaCl, 0.1% Tween
20 (v/v), pH 8.0). Blots were then incubated with primary
antibodies against phosphorylated forms of JNK, p38
MAPK, ERK1/2, AKT1 (Ser473) and BAD (Ser136) (dilu-
tion 1:4000) or with primary antibody against ASM (dilu-
tion 1:400) in incubation buffer followed by incubation with
alkaline phosphatase-conjugated anti-rabbit immunoglobu-
lin (dilution 1:1500). Blots were developed with BCIP/NBT
liquid substrate system. Loading controls using primary
antibodies against unphosphorylated forms of JNK, p38
MAPK, ERK1/2 and AKT were performed following the
same procedure.
2.6. Electron microscopy
HASM were grown in petri dishes (F = 10 cm) and
growth-arrested as described. Afterwards they were incu-
bated with or without mmLDL (60 Ag apo B/ml) in
DMEM+0.1% FCS. Cells were isolated and prefixed with
3% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2.
After washing with cacodylate buffer, cells were fixed with
1% osmium tetroxide in the same buffer, dehydrated by
passing the samples through a series of ethanol solutions
of increasing strength (30–100%) and embedded in Agar
EPON 812. Ultrathin sections were prepared using a Leica
Ultracut ultramicrotome, stained with uranyl acetate and
lead citrate and viewed with a Philips EM 420 electron
microscope.3. Results
3.1. Activation of protein kinases by native LDL, mmLDL
and ceramide
The effects of mmLDL and native LDL were investi-
gated on activities of the mitogen-activated protein
kinases (MAPKs) c-Jun N-terminal kinase/stress-activated
kinase (JNK), p38 MAPK and extracellular regulated
kinase 1/2 (ERK1/2) in SMCs. JNK and p38 MAPK,
which are involved in stress response, inflammation and
apoptosis [20,21], are phosphorylated to a substantially
higher extent upon stimulation with mmLDL (60 Ag apo
B/ml) than by native LDL (60 Ag apo B/ml, Fig. 1). In
both cases, the activation maximum was reached after 10
min of incubation with mmLDL. In contrast, phosphory-
lation of ERK, which plays an important role in prolif-
eration, growth and differentiation [22], is induced by
native LDL to a larger extent than by mmLDL within 5–
30 min.
In order to understand which upstream signaling ele-
ments are involved in mmLDL-triggered activation of
MAPKs the effects of ceramide were studied. Ceramide
activated all three MAPKs under investigation (Fig. 1, right
lane). Ceramide is formed by enzymatic hydrolysis from
sphingomyelin. Thus, the effects of mmLDL on sphingo-
myelinases in smooth muscle cells were also studied (see
following section).
In addition to ERK, AKT kinase is another protein kinase
that plays an important role in cell proliferation and surviv-
al. Thus, it was of interest to find out whether this protein
kinase and its substrate BAD get phosphorylated as a
Fig. 2. Effect of native LDL, mmLDL and ceramide on AKT-kinase and its
substrate BAD. HASM were incubated with native LDL, mmLDL (60 Ag
apo B/ml, each) or ceramide (10 AM) for 30 min. Phosphorylation of AKT
and BAD as well as unphosphorylated levels of AKT were determined by
Western blotting with anti-phospho-AKT, anti-AKT and anti-phospho-BAD
antibodies. Data are representative of three independent experiments.
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er, mmLDL (60 Ag apo B/ml) hardly stimulated phosphor-
ylation of AKT and BAD (Fig. 2). In contrast, stimulation of
cells with native LDL (60 Ag apo B/ml) for 30 min resulted
in a noticeable increase of both AKT and BAD phosphor-
ylation. Ceramide (10 AM) was able to induce phosphory-
lation of AKT and BAD in SMC as well, underlining its
potential of mediating signals in both directions, cell death
and growth.
In all these cases, the unphosphorylated forms of MAPKs
and AKT were not affected by either natLDL, mmLDL or
ceramide.
3.2. Effect of mmLDL and native LDL on neutral and acid
sphingomyelinase
SMases generate ceramide, and thus, participate in
signaling leading to apoptosis or proliferation depending
on the conditions of oxidative stress [23]. mmLDL (60
Ag apo B/ml) induced a substantial increase of aSMase
activity up to 200% as compared to the untreated controlFig. 3. Effects of native and mmLDL on aSMase and nSMase activity.
HASM were treated with native or mmLDL for 30 min, followed by
isolation and lysis in lysis buffer for assaying neutral and acid SMase,
respectively. Enzyme activities were determined as described previously
[17]. Data shown are meanF S.D. (nz 3–5).whereas native LDL showed much lower effects (130%
activity of control, Fig. 3). nSMase activity was also
stimulated by mmLDL up to 300% of control, but nearly
the same extent of nSMase activation was found upon
incubation of SMC with native LDL for 30 min (260%
of control).
3.3. Effect of an inhibitor of aSMase on ceramide- and
mmLDL-induced activation of sphingomyelinases
To find out whether the MAPKs p38 and JNK on the one
hand or ERK and AKT on the other hand are potential
downstream targets of acid sphingomyelinase, we ‘‘re-
moved’’ the enzyme from the signaling cascade by treat-
ment of SMCs with NB6. The latter compound specifically
inhibits aSMase expression (and activity) in macrophagesFig. 4. Effects of mmLDL, ceramide and NB6 on aSMase. (A) Cells were
stimulated with mmLDL (60 Ag apo B/ml) or ceramide (10 AM) after or
without pretreatment with NB6 (10 AM) for 30 min followed by cell lysis in
acid lysis buffer. Enzyme activities were determined using NBD-labelled
sphingomyelin as substrate [17]. NBD-ceramide formed was separated
from the remaining substrate by TLC on silica gel. An image of TLC
analysis of fluorescent NBD-lipids is shown which was obtained using a
CCD-camera. (B) aSMase activities were determined from the formation of
fluorescent NBD-ceramide and calculated as percentage of control.
Indicated values are meanF S.D. (n= 3–4). (C) HASM were treated with
NB6 (10 AM) for 10 –30 min and total protein levels of acid
sphingomyelinase were analyzed by Western blotting using anti-ASM
antibodies. Data are representative for three independent experiments.
Fig. 5. Effects of mmLDL, ceramide and NB6 on nSMase activity. Cells
were stimulated by mmLDL (60 Ag apo B/ml) or ceramide (10 AM) after or
without pretreatment with NB6 (10 AM) for 30 min followed by cell lysis in
neutral lysis buffer and determination of enzyme activities (see legend to
Fig. 4). (A) TLC analysis of fluorescent lipids (the image was obtained
using a CCD camera). (B) nSMase activities as determined from the
formation of fluorescent ceramide. Indicated enzyme activities are
meansF S.D. (n= 3–4).
Fig. 6. Effects of mmLDL, ceramide and NB6 on phosphorylation of
MAPKs, AKT-Kinase and BAD. HASM were incubated with mmLDL (60
Ag apo B/ml) or ceramide (10 AM) after or without pretreatment with NB6
(10 AM) for 30 min. Western blot analysis of samples containing 20 Ag
protein were performed to determine phosphorylation of JNK, p38 MAPK,
ERK, AKT and BAD as well as unphosphorylated forms of MAPKs and
AKT as described in the legends to Figs. 1 and 2. The same results were
obtained in three independent experiments.
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protein levels and activity of acid sphingomyelinase in
smooth muscle cells (see Fig. 4). As a consequence,
mmLDL- and ceramide-induced activation of this enzyme
was abolished as well.
For determination of enzyme activity fluorescent N-7-
nitrobenz-2-oxa-1,3-diazol (NBD)-sphingomyelin was used
as a substrate to measure SMase activity from the amount of
NBD-ceramide formed [17].
Fig. 4 shows the formation of fluorescent ceramide as
a consequence of cell stimulation and aSMase-activation
by mmLDL (60 Ag/ml) or C6-ceramide (10 AM) for 30
min. C6-Ceramide was taken as the stimulus in this case
since some studies had already revealed that ceramide
itself could act as an inducer q of SMase activity in
macrophages and other cells via a possible auto-feedback
mechanism [12]. Pretreatment of SMC with NB6
inhibited stimulation of acid sphingomyelinase activity
by mmLDL or ceramide. aSMase activity in cells pre-
treated with NB6 was even lower than SMase activity in
untreated and unstimulated controls. Fig. 4C shows
Western blots demonstrating that NB6 (10 AM, 10–30
min) significantly reduced protein levels of acid sphingo-
myelinase, too. This is in line with the effects that NB6
shows on expression of aSMase in fibroblasts and macro-
phages [12].In order to confirm that NB6 specifically inhibited
aSMase and did not affect the neutral isoform, nSMase
activity after pretreatment with NB6 was investigated.
Activation of this SMase isoform by mmLDL or ceramide
was not influenced by NB6 (Fig. 5).
It has to be emphasized that the experiments involving
NB6 were solely carried out to confirm that the presence
of aSMase protein is required for initiating the apoptotic
MAP kinase cascade. It has nothing to do with the
mechanisms of aSMase activation itself, which is very
likely to be induced physically on the protein or mem-
brane level, since activation requires only a few minutes
of contact between the cells and the stimuli (ceramide or
mmLDL).
Fig. 8. Transmission electron micrographs showing the effects of mmLDL
on cell morphology. Cells were incubated without (control, left panel) or
with mmLDL (60 Ag apo B/ml, right panel) for 8 h, isolated and fixed by
3% glutaraldehyde in 0.1 M cacodylate buffer for 1 day. After fixing, cells
were washed, embedded and visualized by transmission electron micros-
copy with 6600-fold magnification. Changes in cell morphology after
incubation with mmLDL as compared to the untreated control are indicated
by black arrows (1—membrane blebbing; 2—chromatin condensation; 3—
fragmentation of the nucleus).
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mmLDL- and ceramide-induced activation of MAPKs, AKT/
PKB and BAD
Since NB6 was identified as a specific inhibitor of
aSMase at a transcriptional level (see above), it was further
applied to study the role of this enzyme in mmLDL- and
ceramide-induced signaling. Thus, aSMase expression was
reduced by preincubation of cells with NB6, prior to
stimulation with mmLDL or ceramide.
NB6 prevented mmLDL- and ceramide-induced activa-
tion of JNK and p38 MAPK, whereas it did not show any
effects on phosphorylation of ERK1/2 (Fig. 6A). mmLDL-
and ceramide-induced phosphorylation of AKT and BAD
also remained unaffected after pretreatment with the aSMase
inhibitor (Fig. 6B). Thus, aSMase is rather involved as an
upstream element of JNK and p38 MAPK in mmLDL-
induced (apoptotic) signaling in SMC. Phosphorylation of
JNK and p38 MAPK as a consequence of cell stimulation
by ceramide was also inhibited by NB6. Hence, aSMase
seems to be activated by an auto-feedback mechanism
involving ceramide, its enzymatic product. On the other
hand, aSMase in smooth muscle cells is not very likely to be
involved in signaling q, leading to proliferation q.
3.5. Influence of the aSMase-inhibitor D609 on mmLDL-
induced activation of p38 MAPK and JNK
In order to exclude the possibility that NB6 interferes
directly with one of the MAPKs, the effect of NB6 on p38
MAPK and JNK was compared to the action of the well-
described and very specific aSMase-pathway inhibitor D609
[24–27]. Fig. 8 shows that D609, like NB6 abrogated
mmLDL-induced activation of p38 MAPK and JNK (Fig.
7) providing additional evidence for the assumption that
A. Loidl et al. / Biochimica et BFig. 7. Effects of NB6 as compared to D609 on phosphorylation of JNK
and p38 MAPK. Cells were incubated with mmLDL (60 Ag apo B/ml) after
or without pretreatment with NB6 and D609 (10 AM each), for 30 min,
respectively. Western blots for determination of phosphorylated JNK and
p38 MAPK as well as total MAPKs were performed as described in the
legends to Figs. 1 and 2.aSMase is upstream of these two protein kinases. Since NB6
and D609 act very much the same way in inhibiting aSMase,
we may at least conclude that direct interaction of both
inhibitors with downstream MAPKs are very unlikely.
3.6. Morphological changes of smooth muscle cells induced
by mmLDL
Since mmLDL activated apoptotic signaling in SMCs,
we investigated the possibility that morphological changes
of the cells typical of apoptosis would also occur. For this
purpose we used transmission electron microscopy. After
treatment with mmLDL (60 Ag apo B/ml), human arterial
smooth muscle cells showed all signs of apoptotic cell
death. In contrast to the untreated control (Fig. 8, left), the
cells exposed to mmLDL (Fig. 8, right) showed membrane
blebbing, fragmentation of the nucleus, chromatin conden-
sation and decrease of cell volume. Smooth muscle cells
treated with native LDL for 8 h did not show any morpho-
logical changes at all (data not shown).4. Discussion
Proliferation and apoptosis of arterial SMC play an
important role in the development of atherosclerosis.
Whereas cell proliferation contributes to the formation of
the atherosclerotic plaques at the earlier stages of athero-
sclerosis, apoptosis occurs in the later phases and can be
detrimental, since SMC produce most of the interstitial
collagen fibers important for the tensile strength of the
fibrous cap. Thus the presence of apoptotic smooth muscle
cells in atherosclerotic lesions contributes to the instability
of the lesion and cell death might also be a primary cause for
induction of inflammatory responses [5].
Fig. 9. Intracellular signaling induced by mmLDL. mmLDL induces
specific signaling cascades via generation of ceramide by acid sphingo-
myelinase followed by activation of p38 MAPK and JNK. Ceramide in
turn, stimulates aSMase via an auto-feedback mechanism, thus amplifying
the signal transmitted to the downstream targets p38 MAPK and JNK.
Survival and proliferation pathways depending on ERK and AKT/PKB are
not activated. As a consequence, mmLDL preferentially leads to apoptosis
of vascular smooth muscle cells.
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formation of atherosclerotic plaques. It exerts various
effects on all cells of the arterial wall by triggering very
different responses. Depending on concentration and the
extent of oxidation, oxLDL may lead to both proliferation
and apoptosis of smooth muscle cells [28,29]. Most
studies concerning the effects of oxLDL on SMCs were
carried out with highly oxidized LDL. This particle
contains both oxidized proteins and lipids. A less exten-
sively oxidized form of LDL is represented by mmLDL,
which contains oxidized lipids and hardly shows any
protein modification. It resembles much more the oxLDL
present in vivo [30].
Proliferative and apoptotic responses of SMCs to oxida-
tive stress are mediated by several signal transduction
pathways [4,5]. The sphingolipid ceramide plays a key role
as a mediator in numerous signaling pathways induced by a
variety of stress factors in various cell types including
mitogens or cytokines such as TNFa, IFNg, IL-1, FasL,
PDGF, UV as well as oxLDL [31]. It is formed after
activation of sphingomyelinases under the influence of the
above substances [9]. Two enzyme isoforms play a key role
in signal transduction, namely a neutral Mg2 +-dependent
sphingomyelinase and an acid isoform, both of which can be
activated by stress, e.g. by oxLDL [32]. It was the aim of
this study to identify the role of sphingomyelinases and their
product ceramide on the signaling cascades in SMC that are
triggered by mmLDL.
nSMase was activated by native LDL and mmLDL to a
similar extent. In contrast, aSMase was activated much more
efficiently by mmLDL than by native LDL. SMase activa-
tion was accompanied by fast phosphorylation of p38
MAPK and JNK, which are involved in stress response,
inflammation and apoptosis [20,21]. These effects were not
observed when the cells were stimulated with native LDL.
Obviously, the oxidized lipid component must be responsi-
ble for the effects of mmLDL on acid sphingomyelinase,
p38 MAPK and JNK since both lipoproteins (native LDL
and mmLDL) contain the same (unmodified) apolipoprotein
B. On the other hand, activation of aSMase and the protein
kinases was induced by ceramide. We conclude from this
observation that ceramide may serve a dual function. On the
one hand, it acts as a second messenger to propagate the
mmLDL signal. On the other hand, it acts via a positive
feedback mechanism since it potentiates the action of the
enzyme by which it is generated.
mmLDL failed to stimulate the phosphorylation of an-
other member of the MAPK family namely p42/44 MAPK
(ERK), which is involved in induction of proliferation,
growth and migration [22]. However, the latter enzyme
was phosphorylated upon exposure of SMCs to native
LDL. This is in line with observations by Locher et al.
[33], who demonstrated that native LDL gives rise to the
formation of ROS and subsequent activation of ERK, which
might be important for mitogenic signaling in SMCs.
Activation of ERK was also observed after stimulation ofSMC by ceramide, suggesting that SMases might play a role
in this context as well.
Furthermore, the effects of mmLDL and native LDL on
AKT kinase was studied, which counteracts apoptosis. This
protein is phosphorylated by PDKs and as such inhibits
programmed cell death since it phosphorylates and, as a
consequence, inhibits BAD, an apoptotic member of the
Bcl2-family [34]. mmLDL hardly showed any effects on
AKT phosphorylation, whereas cell treatment by native
LDL or ceramide led to high phosphorylation of AKT and
BAD. Obviously, ceramide is involved as a lipid mediator in
apoptotic and anti-apoptotic signaling pathways depending
on the conditions of activation.
Our results are at variance with other studies reporting on
the induction of SMC proliferation and activation of ERK
and AKT by oxLDL [35–37]. However, these studies were
carried out with highly oxidized LDL, in which both the
protein and lipid components were modified. In contrast,
our experiments were performed with mmLDL, in which
mainly the lipid domains are oxidized. The differences
among our results and those obtained from other groups
give another hint that the signaling pathways investigated in
this study are triggered, if at all, by the oxidized lipid
component of mmLDL. In contrast, activation of prolifera-
tive and survival pathways like AKT and ERK by oxLDL
might be due to the action of oxidized apolipoproteins
guiding the lipoprotein particle to the scavenger [38] instead
of the apo B/E receptor and thus, another signaling pathway.
SMases are essential catalysts for the formation of
ceramide as upstream elements in mmLDL-induced signal-
ing in SMC. To find out whether aSMase is responsible for
the ceramide-associated signaling in this study, we used a
novel inhibitor of aSMase (NB6) which suppresses protein
synthesis at the transcriptional level [12]. We provided
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and that reduction of aSMase expression specifically inhib-
its subsequent activation of aSMase by mmLDL or ceram-
ide. In contrast, it did not show any effects on mmLDL- and
ceramide-triggered activation of the neutral isoform.
Activation of aSMase seems to be reinforced by a
positive feedback mechanism, involving ceramide, which
is formed by this enzyme (Fig. 9). Ceramide shows a wide
spectrum of biophysical and biochemical activities. In
membranes, it may induce microdomains, ceramide chan-
nels or vesicle budding. As a second messenger it may
affect various enzymes of intracellular signaling [39,40]. In
the latter context, it does not only activate MAPKs and
AKT kinase, but also sphingomyelinases, thus amplifying
the primary signal of the cascade. This assumption is
further supported by the finding that reduction of aSMase
protein levels by NB6 inhibited both mmLDL- and ceram-
ide-induced activation of aSMase. In addition, this com-
pound abrogated mmLDL- or ceramide-induced
phosphorylation of the apoptotic protein kinases p38
MAPK and JNK by means of inhibition of aSMase
expression. In contrast, phosphorylation of ERK, AKT
and BAD, the elements involved in cell proliferation and
survival, was not affected by NB6. Taken together these
data suggest an essential and specific role for aSMase in
apoptotic signaling of smooth muscle cells under the
influence of mmLDL.Acknowledgements
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